"Remember that FLUCIDE did not just come about by accident."
Did I ever say that it did? So what? -- most new drugs these days don't come about by accident.
"It is not made in a chemisty lab and not in an industrial factory and is made by medical doctors after years of research in a special laboratory."
Fluicide is made in a bio-chemistry lab just like all those other drugs. Its inventors are doctors and PhDs, just like for all those other drugs. They are attempting to scale up production by - gasp! -- making it in a factory in Connecticut. Sorry, fluicide isn't that special -- it's a drug with a different mode of action than other drugs, but it's still a drug. You look at its unique mode of action and say Fluicide must be much safer than other drugs. The FDA will agree that its mode of action is unique, and that it's entirely different from any other drug that's been tried in humans. For precisely that reason I'm sure they'll be even more demanding than usual of data for safety in humans. It will cost money to meet those demands.
"Over 3500 tests in animals shows no or little toxicity."
You could have said the same thing about methanol.
"The formulas of FLUCIDE are intended to go after the VIRUSes and not the host. Only the viruses will be affected."
Intention and reality are two different things. We won't know that it doesn't have any deleterious effects on humans until we test it on humans.
"Any toxic assertions are assertions only at this time."
Any safety assertions are only assertions at this time.
All your hand waving and special pleading can not change the underlying reality. The safety and efficacy of Fluicide must be tested, and with the same arduous and expensive procedures as are used for other drugs. Investors are holding back because they can add up the numbers, and are wondering just how many more dilutions of shares have to take place before profitability is reached, especially after they take into account that NNVC never meets its deadlines.
